1. Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: A 2-year MRI study. (August 2019) Authors: Cacciaguerra, Laura; Pagani, Elisabetta; Mesaros, Sharlota; Dackovic, Jelena; Dujmovic-Basuroski, Irena; Drulovic, Jelena; Valsasina, Paola; Filippi, Massimo; Rocca, Maria Assunta Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition. (August 2019) Authors: Lin, Fuchun; Zivadinov, Robert; Hagemeier, Jesper; Weinstock-Guttman, Bianca; Vaughn, Caila; Gandhi, Sirin; Jakimovski, Dejan; Hulst, Hanneke E; Benedict, Ralph HB; Bergsland, Niels; Fuchs, Tom; Dwyer, Michael G Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: A Chinese pilot study. (August 2019) Authors: Gong, Junli; Qiu, Wei; Zeng, Qin; Liu, Xiyuan; Sun, Xiaobo; Li, Huijuan; Yang, Yu; Wu, Aimin; Bao, Jian; Wang, Yuge; Shu, Yaqing; Hu, Xueqiang; Bellanti, Joseph A; Zheng, Song Guo; Lu, Yongjun; Lu, Zhengqi Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study. (August 2019) Authors: Cohen, Jeffrey A; Comi, Giancarlo; Arnold, Douglas L; Bar-Or, Amit; Selmaj, Krzysztof W; Steinman, Lawrence; Havrdová, Eva K; Cree, Bruce AC; Montalbán, Xavier; Hartung, Hans-Peter; Huang, Vivian; Frohna, Paul; Skolnick, Brett E; Kappos, Ludwig Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary. (August 2019) Authors: Wingerchuk, Dean M Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Disease-modifying therapies should be stopped in NMOSD patients in remission – Yes. (August 2019) Authors: Shosha, Eslam Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: A note of caution. (August 2019) Authors: Feige, Julia; Salmhofer, Hermann; Hecker, Constantin; Kunz, Alexander Baden; Franzen, Michael; Moré, Elena; Sellner, Johann Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'. (August 2019) Authors: Dobson, Ruth Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis. (August 2019) Authors: Holm Hansen, Rikke; Højsgaard Chow, Helene; Sellebjerg, Finn; Rode von Essen, Marina Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CSF β-amyloid predicts prognosis in patients with multiple sclerosis. (August 2019) Authors: Pietroboni, Anna M; Caprioli, Michela; Carandini, Tiziana; Scarioni, Marta; Ghezzi, Laura; Arighi, Andrea; Cioffi, Sara; Cinnante, Claudia; Fenoglio, Chiara; Oldoni, Emanuela; De Riz, Milena A; Basilico, Paola; Fumagalli, Giorgio G; Colombi, Annalisa; Giulietti, Giovanni; Serra, Laura; Triulzi, F... Journal: Multiple sclerosis Issue: Volume 25:Number 9(2019) Page Start: 1223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗